DHR
vs
S&P 500

Over the past 12 months, DHR has underperformed S&P 500, delivering a return of -26% compared to the S&P 500's 12% growth.
Performance By Year
DHR vs S&P 500
Danaher Corp
Glance View
Once upon a time, back in 1984, two brothers, Steven and Mitchell Rales, envisioned a company that would revolutionize the manufacturing sphere, setting the roots for what would become Danaher Corporation. Born from the acquisition of a real estate investment trust, they pivoted to a broader industrial manufacturing approach, aligning themselves with the then unique concept of lean manufacturing and continuous improvement – known as the Danaher Business System (DBS). This philosophy helped them transform Danaher into an assembly of high-performance companies. Over the decades, the corporation honed its focus, shedding non-core assets, and refining its portfolio to center on biotechnology, life sciences, environmental and applied solutions, and diagnostics. Through strategic acquisitions and relentless innovation, Danaher has continued to evolve, constantly reshaping itself to meet the demands of critical sectors. Today, Danaher's operations are driven by three powerful segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. Its Life Sciences segment enables breakthrough discoveries that advance scientific research, healthcare, and more. Meanwhile, the Diagnostics division delivers critical tools that aid clinical laboratories and physicians in patient care, offering blood and infection analysis technologies, among others. Finally, Environmental & Applied Solutions focuses on water quality and product-identification services, crucial for maintaining health and safety standards across industries. By continually investing in innovation and focusing on operational efficiencies through DBS, Danaher not only positions itself as a leader in these sectors—it harnesses market needs into profitable solutions, ensuring its growth and stability in a competitive global market.
